HoloMonitor cell motility assay icon
App Suite_Cell Motility_results page_white background
HoloMonitor cell motility assay icon
App Suite_Cell Motility_results page_white background

App Suite – Kinetic Motility Assay


HoloMonitor® App Suite is a new proprietary software based on biological applications. Using App Suite you can easily perform live cell studies on various cellular events. The App Suite software has an intuitive user interface guiding the user through the simple step-by-step workflow, from set-up of the experiment until the results are presented. HoloMonitor® App Suite is designed for automated and detailed analysis of cell populations. The automated analysis extracts selected cellular parameters that are condensed into quantitative application-specific output parameters.

The HoloMonitor® Motility Assay is designed to explore the average motility of cells in a population and is ideal for studies investigating how various treatments, drug candidates, or environments influence cell motility over time. Cell motility can be studied during long term experiments using normal cell growth media and environment, with no labeling, staining or phototoxicity. Motility is assessed in terms of speed kinetics, i.e. average cell speed over time. In addition, the accumulated mean distance, at each time point, is automatically determined by the software.

Each software license is valid for installation on 2 PCs. Additional licenses can be purchased at 50% of the original cost.

SKU: 50004

Additional information


End-point data given as values per well

Average cell speed


Accumulated mean cell distance


Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2